Rows of towering stainless steel cryogenic tanks dominate a vast underground chamber, stretching out under harsh fluorescent lights. Inside these dewars, filled with liquid nitrogen, lie numerous patients preserved in a state of suspended animation.
This isn’t a scene from a science fiction movie; it’s the interior of the European Biostasis Foundation’s first facility in Rafz, Switzerland, where Berlin startup Tomorrow Biostasis stores its long-term care patients.
Once considered the realm of speculative fiction, cryonic preservation is slowly approaching reality. As longevity medicine drives forward biomedical innovation, initiatives to slow, pause, or even prevent mortality are proliferating at an unprecedented rate. In this era of expanding technological possibilities, researchers and entrepreneurs continually push boundaries to actualize what was once thought impossible.
